江苏蓝丰生物化工股份有限公司 关于向公司2025年限制性股票激励计划激励 对象授予限制性股票的公告

Core Viewpoint - Jiangsu Lanfeng Biological Chemical Co., Ltd. has approved the grant of 20.03 million restricted stocks to 71 incentive objects at a price of 2.64 yuan per share as part of its 2025 restricted stock incentive plan [1][19][26]. Summary by Sections Incentive Plan Overview - The incentive tool is restricted stocks, with a total of 20.03 million shares to be granted, accounting for 5.63% of the company's total share capital of 355,563,978 shares [1][13]. - The grant date is set for November 24, 2025, with a grant price of 2.64 yuan per share [2][14]. Eligible Participants - The incentive plan includes 71 participants, comprising senior management, middle management, and key employees, excluding independent directors and shareholders holding more than 5% of the company's shares [2][15]. Lock-up Period and Release Conditions - The lock-up period for the granted restricted stocks is 12 to 24 months from the date of grant, during which the stocks cannot be transferred or used as collateral [2][3]. - Upon expiration of the lock-up period, stocks that do not meet the release conditions will be repurchased by the company at the grant price [2][3]. Performance Assessment Requirements - The performance assessment period spans 2025 to 2026, with annual evaluations based on achieving performance targets [4][6]. - The performance targets are linked to revenue growth rates and net profit completion rates, determining the release of restricted stocks [6][7]. Approval Process - The plan has undergone necessary approvals, including board meetings and shareholder meetings, with legal opinions confirming compliance with regulations [9][10][20]. - Adjustments to the incentive plan were made due to one participant's departure, reducing the number of participants from 72 to 71 while maintaining the total number of shares granted [41][43]. Financial Impact - The costs associated with the incentive plan will be amortized over the vesting period, impacting the company's financial results as per accounting standards [16][43].